ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Taxus Cardium Pharmaceuticals Group Inc (CE)

Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM)

0.000001
0.00
( 0.00% )
Updated: 20:00:00

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

CRXM News

Official News Only

CRXM Discussion

View Posts
docj docj 4 weeks ago
Thanks JJ24 for reaching him and reporting here. Did he provide anything about how he was going about buying back the company?

Additionally, whoever is funding the buyout beyond Chris, what is their interest in getting the company back to being current in the SEC fikings and trading which is going to have a significant cost. Or do they plan on not being a public traded company?

Then there is the several million dollars needed to fund the trial.
👍️ 1
docj docj 4 weeks ago
Any idea if CRXM responded to the order?

They have let the website sevices go to shit. Not that they would have posted the info anyway. That would show at least some responsibility on their part to keep investors informed.

https://genebiotherapeutics.com/press/

https://genebiotherapeutics.com/investors/
πŸ‘οΈ0
bentleyt bentleyt 1 month ago
Good to hear.....Thanks for your efforts in reaching out......Generx is valuable since its at a Phase 3 Fast Track status!!.....Hopefully a real deal is pending!!!!!!
👍️ 1
JJ24 JJ24 1 month ago
Chris is alive , he said he’s working on buying the company back from Nostrum. Praying he is successful .
👍️ 1
docj docj 1 month ago
Good question. Most likely answer is money. I'm sure it's going to take hundreds of thousands to get current.

If Nostrum isn't able to provide financial support then what good are they? My expectattion was they could fund the trial directly or had resources to get the financing. Perhaps no lender will work with them given their situation. Enough time has passed I'd hoped Chris would have found a way to move things along without Nostrum.
πŸ‘οΈ0
docj docj 2 months ago
No one seems to know anything based on the lack of comments.
πŸ‘οΈ0
benyam benyam 2 months ago
just wondering maybe company not active anymore ????
πŸ‘οΈ0
crazyflavor crazyflavor 2 months ago
Ok, just clarifying. Seems like a running back situation.
πŸ‘οΈ0
lakes lakes 2 months ago
Yes, .10 a share. I am hedging my bet in case they actually bring this thing back to life. If you are making a serious offer, you must have reason to believe it will come back. They have never responded to my emails so I am completely blind but you may not be.
πŸ‘οΈ0
crazyflavor crazyflavor 2 months ago
So you want 2x what most paid (.05) for shares in a company you think is dead? Or did you mean .01?
πŸ‘οΈ0
lakes lakes 2 months ago
I can't respond privately so will do it here. Absolutely, I would be interested in selling my shares to you. I am going to give them time to respond to the SEC complaint before selling. If it looks like Reinhard will let it die on the vine, as someone else suggested, then you can have all of my 800,000 shares for .10 a share. Subject to change, of course.
πŸ‘οΈ0
lakes lakes 2 months ago
Of course, if I could!
πŸ‘οΈ0
bentleyt bentleyt 2 months ago
Jan 29 2024.....Altitrade Posted......"Still confident that things will eventually come together".....I wonder what they think of this new SEC notice?
👍️ 1
RyNo_23 RyNo_23 2 months ago
I did.

No reply yet.
πŸ‘οΈ0
docj docj 2 months ago
Anyone reached out to CRXM management about this?
πŸ‘οΈ0
crazyflavor crazyflavor 2 months ago
So you’d sell your shares?
πŸ‘οΈ0
lakes lakes 2 months ago
That has been my hope for years but at this point, I seriously doubt there is any value here. If I remember correctly, this thing was fast tracked for phase 3 testing almost 20 years ago and Reinhard has been unable to even start it. If there was any value here, someone would have found it by now.

πŸ‘οΈ0
campe campe 2 months ago
Thanks for posting. Let's see if they respond to the order or let this thing die in the vine.

There is still valuable IP here, so maybe some other biopharma sees potential and takes it over.

πŸ‘οΈ0
Renee Renee 2 months ago
CRXM: SEC Admin. Proceeding for severely delinquent Financials:

https://www.sec.gov/files/litigation/admin/2024/34-99675.pdf
πŸ‘οΈ0
docj docj 2 months ago
Another month has gone by with nothing from the company. Silence sucks.
πŸ‘οΈ0
JJ24 JJ24 3 months ago
I wonder why they just can’t get current so this can trade . If they need money to fund Phase 3 , get current , Raise the OS and sell shares . If I could get out at .01 I would be stoked.
πŸ‘οΈ0
docj docj 3 months ago
I wonder what the current situation with Nostrum is with their interest and financial means to move things forward.
πŸ‘οΈ0
bentleyt bentleyt 3 months ago
Altitrade thanks.....Good to hear!
👍️ 1
Altitrade Partners Altitrade Partners 3 months ago
Still confident that things will eventually come together and CRXM will begin trading again. In for the long haul.
👍️ 3
docj docj 3 months ago
Three months ago this was his position. I am curious if anything has changed:

Altitrade Partners

Re: bentleyt post# 6073

Tuesday, October 24, 2023 10:27:41 AM

Post#
6074
of 6111
What makes you feel so confident?

- A strong belief in GeneRx drug therapy and CEO Chris Reinhard's ability to get it to the market.

What do you honestly see for the future of CRXM

- Sorry, our crystal ball is currently in the shop for repair.

What is your anticipated timeframe?

- As long as it takes
👍️ 1
bentleyt bentleyt 3 months ago
Altitrade......Any thoughts where CRXM is headed
👍️ 1
docj docj 4 months ago
I'm kind of curious myself.

My take on CR is he's a pretty bright guy and means well. I question whether he has the skillset to raise funds at this point to move research forward. Clearly he put all of his, and our eggs in the Nostrum basket. Now that Nostrum is in a bad way, what is the work around?

One would think Mr Grainer would have the know how and contacts to make this happen but here we sit almost three years since the last meaningful news release and nearly 2 years since the last filing.
πŸ‘οΈ0
DreamyOcean80 DreamyOcean80 4 months ago
_fatty_, When you refer to him as a clown, are you implying it solely based on his makeup and large shoes? I'm inclined to think that's not your actual point. Could you elaborate on any specific actions of the CEO that substantiate your claim?
πŸ‘οΈ0
_fatty_ _fatty_ 4 months ago
Makeup and the oversized shoes

What makes a clown, a clown?
👍️ 1
DreamyOcean80 DreamyOcean80 4 months ago
_fatty_, I humbly present to you the question "What makes this CEO a clown?" I assure you is borne out of genuine interest. Your answer to this question may benefit this board readers and myself.
πŸ‘οΈ0
_fatty_ _fatty_ 4 months ago
Yep, both replies to my posts. Isn’t that coincidence and not weird at all. If I had to guess who went ahead and created a second account just to respond to my posts, I could probably guess on the first try.
πŸ‘οΈ0
Gnarlyman Gnarlyman 4 months ago
You should be welcoming that Acct to IHUB. Fresh one with only 2 post.
πŸ‘οΈ0
docj docj 4 months ago
Welcome to the board. Best of luck to you.
πŸ‘οΈ0
DreamyOcean80 DreamyOcean80 4 months ago
_fatty_, What makes this CEO a clown?
πŸ‘οΈ0
RyNo_23 RyNo_23 4 months ago
Nobody gives a $hit about shareholders. I'll hold all my worthless shares till end of 2024...then if nothing. BIG TAX write off.

Some say the key is not to lose big....well, $hit happens. We take risks - that's life.
πŸ‘οΈ0
docj docj 4 months ago
The thing that bothers me is Nostrum has been under financial pressure for going on a couple years now. If they had helped with the funding early on we would be at the end of the trial by now and potentially have a big pharma partner or have been bought out. This would have put Nostrum in a much stronger financial position as well as shareholders.

I have no doubt Chris Reinhard has known about these issues for quite some time and nothing has changed. As far as I know he has not publicly communicated with shareholders in a very long time. I know several have reached out with little or no success.

For Pete's sake, our COB/CFO is Nostrum's CFO (as far as I know). How can this not be handled more optimally given such tight control?

A New Year is here. Nostrum knows their punishment from the Feds. It is time for them to figure out the plan AND inform CRXM shareholders.
👍️ 1
bentleyt bentleyt 4 months ago
docj.....What you found is the reason why CRXM has stalled out.....We need a solid Pharma company to buy out Nostrum's CRXM ownership position and get rid of them forever.....Thanks for your Due Diligence
πŸ‘οΈ0
docj docj 4 months ago
I'm not sure Nostrum Pharma or Nostrum Lab exists anymore. Website links do not work for me. Could be they are rebranding I suppose. Either way Gene Bio is probably low on their to do list funding wise.
πŸ‘οΈ0
docj docj 4 months ago
You may be correct about Gene Bio's ability to move things ahead. That was the whole idea about bringing in the pharma group. But I doubt Chris Reinhard expected Nostrum to have this happen which I just found using Google:

https://www.justice.gov/opa/pr/drugmaker-nostrum-and-its-ceo-agree-pay-50-million-settle-false-claims-act-claims
πŸ‘οΈ0
bentleyt bentleyt 4 months ago
Generx Is Still A Phase 3 Fast Tracked Heart Drug That Works.....The CEO Told Me A Year Or So Ago That Generx Is 10 Years Ahead Of Any Competition....Generx Was Featured On The Cover Of Scientific American In 2017 For A Reason.....CRXM Could Easily Be Brought Out By A Top Biotech Looking For A Late Stage Drug Prospect.....IMHO This Could Turn On A Dime And Become A Winner For Shareholders.....Sure This Investment Has Been A Nightmare So Far But Hope Still Prevails!
👍️ 2
lakes lakes 4 months ago
And so far, very wrong. Their opinion is usually couched in vague optimism but it is obvious to me, this turkey is done. They were fast tracked for phase 3 many years ago and have done squat, not to mention they have been dark for 2 or 3 years. I am pretty sure this will go down as a losing pick for Altitrade.
However, they will be the first to say "win some, lose some".
πŸ‘οΈ0
bentleyt bentleyt 4 months ago
docj......Maybe Altitrade Can Offer Their Advice.....They Are Very Knowledgable Regarding CRXM
πŸ‘οΈ0
docj docj 4 months ago
Anyone have experience in being an activist investor and getting put on the BOD of a public company to help a company move ahead?

I know we have a couple 5% +/- shareholders. Perhaps one might be interested in being our Carl Icahn or Bill Ackman.
πŸ‘οΈ0
_fatty_ _fatty_ 4 months ago
CEO is a clown. SEC is a joke. They pick and choose specific targets to go after. Useless. Don’t expect much from either.

Hope you had a good year and you can just write this loss off and move on
πŸ‘οΈ0
alidare alidare 4 months ago
ππ‘π„π€πŠπˆππ† 🚨 𝗨𝗑𝗣π—₯π—˜π—–π—˜π——π—˜π—‘π—§π—˜π—— π—–π—’π—‘π—šπ—₯π—˜π—¦π—¦π—œπ—’π—‘π—”π—Ÿ π—’π—£π—˜π—‘ π—Ÿπ—˜π—§π—§π—˜π—₯ 𝗧𝗒π—ͺ𝗔π—₯𝗗𝗦 π—§π—›π—˜ 𝗨.𝗦. π—₯π—˜π—šπ—¨π—Ÿπ—”π—§π—’π—₯𝗦 π——π—˜π— π—”π—‘π——π—œπ—‘π—š 𝗧π—₯𝗔𝗑𝗦𝗣𝗔π—₯π—˜π—‘π—–π—¬ 𝗙𝗒π—₯ π—₯π—˜π—§π—”π—œπ—Ÿ π—œπ—‘π—©π—˜π—¦π—§π—’π—₯𝗦 $MMTLP @FINRA @SECGov @GaryGensler

🚨LIVE🚨 with… pic.twitter.com/1nP79twB8D— Meta News🚨 (@MMATNEWS) December 22, 2023

πŸ‘οΈ0
docj docj 4 months ago
Neither the CEO, the COB nor the SEC are willing to comment on whether Sabby/Mintz were shorting CRXM. I've asked.
πŸ‘οΈ0
alidare alidare 4 months ago
I remember Sabby was here:

β€œA recent one that’s received a good deal of attention involves Hal D. Mintz and his firm, Sabby Management LLC, which managed two private funds. Sabby mismarked tickets for short sales, saying they were long sales. By selling without borrowing stock, the firm was unable to make delivery. In addition:
The SEC’s complaint further alleges that Sabby Management and Mintz tried to conceal their fraudulent trading, including by using securities acquired after the trades to make it appear to brokers executing the trades that they had complied with the requirement to have borrowed or located the shares prior to their trades. As the complaint alleges, when questioned by at least one broker regarding their trading, Sabby Management and Mintz repeatedly lied about the trading.”

https://www.securitieslawyer101.com/2023/what-short-selling-is-and-isnt/

πŸ‘οΈ0
Gnarlyman Gnarlyman 5 months ago
I’ll hold these until I croak, but it would be really cool to see this company come out of nowhere and surprise everyone.

Not holding my breath though.
πŸ‘οΈ0
_fatty_ _fatty_ 5 months ago
Year coming to an end. Hope y'all had a great year to write off this trash
πŸ‘οΈ0
bentleyt bentleyt 5 months ago
Yes All The Best And Hopefully We See A Big Turnaround For CRXM
👍️ 1

Your Recent History

Delayed Upgrade Clock